- JNJ +0.12%
Is Johnson & Johnson (JNJ) the Best Cancer Stock to Buy Now?
Yahoo Finance · 18 hours ago
Open | 167.81 |
High | 168.85 |
Low | 166.04 |
Mkt Cap | 402.88B |
P/E (TTM) | 25.36 |
Div & Yield | 4.96 & 2.97% |
Prev. Close | 167.16 |
52 Wk. Low | 143.13 |
52 Wk. High | 168.85 |
Related stocks
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
Johnson & Johnson is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Wikipedia
(USD) | Q2 2024 | Y/Y |
---|---|---|
Revenue | 22.45B | 4.30% ▲ |
Net Income | 4.69B | 8.90% ▼ |
Diluted EPS | 2.82 | 1.60% ▼ |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q3 2024 | $2.18 | - |
Q2 2024 | $2.70 | $2.82 |
Q1 2024 | $2.64 | $2.71 |
S&P 500^GSPC | 5,520.07-8.86 (-0.16%) |
Dow 30^DJI | 40,974.97+38.04 (+0.09%) |
Nasdaq^IXIC | 17,084.30-52.00 (-0.30%) |
29.38-17.47% | |
23.01-1.88% | |
63.56-22.16% |